Related Experiment Video
Updated: Jul 18, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression
Ofira Einstein1, Nina Fainstein, Ilan Vaknin
1Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Annals of Neurology
|December 26, 2006
Summary
Intravenous neural precursor cell (NPC) therapy reduces inflammation and severity in experimental autoimmune encephalomyelitis (EAE). NPCs exert peripheral immunosuppressive effects by inhibiting T-cell activation and proliferation in lymphoid organs.
Area of Science:
- Neuroimmunology
- Stem Cell Therapy
Background:
- Experimental autoimmune encephalomyelitis (EAE) is a model for multiple sclerosis.
- Neural precursor cells (NPCs) have shown potential in treating EAE.
Purpose of the Study:
- To investigate the immunomodulatory effects of systemically administered NPCs in EAE.
- To explore the interaction between NPCs and T cells.
Main Methods:
- Systemic administration of NPCs in EAE models.
- In vitro coculture of NPCs and T cells.
- In vivo assessment of T cell encephalitogenicity.
Main Results:
- Intravenous NPC therapy significantly reduced CNS inflammation, tissue injury, and EAE severity.
- NPCs were found in lymphoid organs, not the CNS.
- NPCs inhibited T cell activation and proliferation, leading to reduced encephalitogenicity.
Conclusions:
- Systemic NPC administration ameliorates EAE through peripheral immunosuppression.
- NPCs exert a bystander inhibitory effect on T cells in lymph nodes.
